This study aims at assessing the efficacy, reliability, and clinical impact of Amniotic Fluid analysis by Nanopore DNA sequencing compared to the standard bacterial cultures in detecting intra-amniotic/inflammation in patients with short cervix or premature rupture of membranes.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
300
Amniotic fluid by amniocentesis or by sterile cervical aspiration via the vagina
Fondazione Policlinico Universitario A. Gemelli IRCCS
Roma, RM, Italy
RECRUITINGMicrobiological analysis of amniotic fluid by next generation analysis
Presence and concentrations of bacteria in amniotic fluid
Time frame: From date of enrollment to the end of pregnancy (up to 9 months)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.